Compare ONON & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONON | HOLX |
|---|---|---|
| Founded | 2010 | 1985 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Medical Electronics |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.8B | 16.6B |
| IPO Year | 2021 | 1990 |
| Metric | ONON | HOLX |
|---|---|---|
| Price | $48.11 | $75.09 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 21 | 15 |
| Target Price | $62.57 | ★ $79.64 |
| AVG Volume (30 Days) | ★ 6.2M | 2.9M |
| Earning Date | 11-12-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.51 | N/A |
| EPS | 0.84 | ★ 2.49 |
| Revenue | $3,607,815,596.00 | ★ $4,100,500,000.00 |
| Revenue This Year | $31.86 | $6.69 |
| Revenue Next Year | $22.90 | $5.74 |
| P/E Ratio | $57.74 | ★ $30.12 |
| Revenue Growth | ★ 33.26 | 1.74 |
| 52 Week Low | $34.38 | $51.90 |
| 52 Week High | $64.05 | $76.29 |
| Indicator | ONON | HOLX |
|---|---|---|
| Relative Strength Index (RSI) | 64.79 | 69.44 |
| Support Level | $45.83 | $74.77 |
| Resistance Level | $50.02 | $75.05 |
| Average True Range (ATR) | 1.75 | 0.28 |
| MACD | 0.37 | -0.12 |
| Stochastic Oscillator | 81.86 | 69.62 |
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.